Background -Unexplained or primary pulmonary hypertension results in an obliteration and obstruction of resistance pulmonary arteries. In these patients gas exchange is impaired
group of patients with unexplained pulmonary hypertension since it is a unique example of a disease which affects the blood vessels rather than the air spaces. The age group affected by the disease allows ready comparison with a matched group of healthy volunteers.
Methods
The measurements were made using an adapted gas transfer apparatus (Transfer Test, PK Morgan, Chatham, UK). Patients and subjects were studied seated at rest. After exhaling to residual volume they inhaled to total lung capacity a gas mixture of 14% helium, 0.3% carbon monoxide (CO), nitric oxide (NO) at 40 parts per million (ppm), 25% oxygen balanced with nitrogen. The breath was held at total lung capacity for 7.5 seconds followed by a full exhalation. After discarding the first litre the remaining exhaled gas was collected for analysis. The inhaled and exhaled gas mixtures were analysed for helium with a katherpharometer, CO by an infrared analyser, NO with a chemiluminescentanalyser(Model42,Thermoelectron, Warrington, UK), and oxygen with a paramagnetic analyser. Each patient and volunteer completed three measurements. Immediately after the last measurement 6 ml of venous blood was obtained from an antecubital vein. The blood was analysed for concentrations of haemoglobin, methaemoglobin, and carboxyhaemoglobin using an automated spectrophotometer (IL282, Instrument Laboratories, Andover, Massachusetts, USA). The mean values for TLNo, TLCO, Dm, and Vc were calculated as previously described": Twelve patients with unexplained pulmonary hypertension diagnosed by right heart Borland, Cox, Higenbottam FEV, = forced expiratory volume in one second; TLCO, TLNo = carbon monoxide and nitric oxide lung transfer factors; Dm = membrane diffusion; Vc = alveolar capillary blood volume; PPA = pulmonary artery pressure.
catheterisation were studied. All the pulmonary hypertensive patients were receiving maximal tolerated vasodilator treatment: six were on long term intravenous infusion of prostacyclin, three were on infusions of iloprost, a prostacyclin analogue, and three were on oral diltiazem, a calcium channel blocker (120 mg three times daily). None had evidence of cardiac or pulmonary disease. Their pulmonary ventilation and perfusion scintograms were normal so excluding pulmonary emboli. Dynamic lung volumes were recorded with dry wedge spirometers (Vitalograph Ltd, Buckingham, UK). Dynamic lung volumes were also measured in 10 healthy volunteers recruited from hospital staff. No patient or volunteer was a current cigarette smoker. The study was approved by the hospital ethics committee and all participants gave written informed consent.
Results
The patients and volunteers had similar ages, heights (table 1) , sex distribution, and haemoglobin. The patients with pulmonary hypertension had smaller dynamic volumes than the volunteers, indicated by the lower value for forced expiratory volume in one second (FEV1) (table 1). Their mean pulmonary pressure and pulmonary vascular resistance were raised compared with the volunteers, and TLCO and TLNO values were significantly reduced to 37.5% and 30.6%, respectively, below the values of the volunteers. Dm for the patients was not significantly less than for the volunteers but the Vc was lower in the patients (table 1).
Discussion
We have applied a new measurement of gas transfer factor, which uses simultaneous recording of the uptake of both NO and CO on inhalation, to patients with severe pulmonary hypertension. The patients had lower values for TLCO and TLNo than a group of volunteers with similar anthropometric characteristics.
Significantly lower values of Vc were found in the patients. The value of Dm was also reduced but this did not reach statistical significance. No statistically significant differences emerged between the treatments but the numbers studied were small. The lower Vc may reflect the reduction in cardiac output'2 which is a characteristic finding in severe pulmonary hypertension. '3 The reduction in cardiac output is a measure of severity of the disease and represents the haemodynamic result of the obstruction and obliteration of the pulmonary arteries.3 Over 80% of the resistance pulmonary arteries of 80-120,m diameter are "lost" in these patients by the time they are diagnosed.'4 An adaptation which allows survival is the development of collateral vessels which bypass the obstructed and narrowed resistance vessels. Although this will lower resistance, such vessels may not be accessible to inhaled oxygen, NO, or CO.'5 However, the adaptation is unlikely to allow full recovery of normal capillary volume leaving Vc reduced in value. Whether this contributes to impaired gas exchange is unclear;
TLCO is measured at total lung capacity during apnoea whereas gas exchange occurs during tidal breathing. If Vc is low in these patients while breathing tidally, it could contribute to hypoxia by shortening capillary transit time or by increasing the capillary resistance to oxygen transfer (1/Q3o2 Vc). In patients with unexplained severe pulmonary hypertension impaired gas exchange is not only due to imbalance of ventilation and perfusion but might also result from a reduction of alveolar capillary blood volume.
